EZH2 and prostate carcinoma: This family of miRNAs has been shown to be deregulated in various cancers such as prostate cancer and neuroblastoma19, 20, as well as malignant schwannoma and meningioma21, potentially through negative regulation of EZH2 (refs 19, 20, 22).